Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

How Can You Mend a Broken Heart - with Stem Cells!

Posted by anna@stemsave.com on May 18, 2016 1:57:00 PM

With a nod to the Bee Gees - Scientists from the University of Utah School of Medicine have successfully treated heart failure patients with autologous stem cells. Patients with stem cell therapy experienced 37% fewer cardiac events--including death and hospital admissions--than a placebo group.

Read More

Topics: stemsaveblog, cardiac arrest, bone marrow, Ischemic Cardiomyopathy, mesenchymal stem cells, regenerative medicine, autologous stem cells

Ischemic Cardiomyopathy Therapy Utilizes Patient’s Own Stem Cells

Posted by pamela@stemsave.com on Dec 7, 2013 5:34:52 AM

Mesenchymal Stem Cells are more effective than bone marrow mononuclear cells in treating Ischemic Cardiomyopathy

A year long clinical trial by the University of Miami Miller School of Medicine has demonstrated that autologous [the patient’s own] mesenchymal stem cells (the type of stem cells found in teeth) are a safe and effective stem cell source for regenerative therapies for the treatment of Ischemic Cardiomyopathy. The study also determined that mesenchymal stem cell treatment was more effective than treatments utilizing bone marrow mononuclear cells.

Read More

Topics: Heart, stemsaveblog, Stemcells, autologousstemcells, Ischemic Cardiomyopathy

Mayo Clinic Utilizes Autologous Stem Cells to Treat Heart Failure Patients in First Clinical Study to Target the Regeneration of a Failing Organ

Posted by taylor@stemsave.com on Jun 7, 2013 2:58:53 PM

Researchers at Mayo Clinic have introduced a new therapy using cardiogenically-instructed stem cells that can improve heart health. This is the first clinical study for the targeted regeneration of a failing organ. The Mayo Clinic study represents what we believe to be the gold standard in regenerative treatments – utilizing the patient’s own stem cells for the therapy. As a result of the use of autologous [the patient’s own] stem cells, there were no complications in any of the patients. Every patient in the stem cell treatment group improved. "The benefit to patients who received cardiopoietic stem cell therapy was significant," said Dr. Terzic – the senior author of the study, with improvements in heart pumping function, physical performance (such as walking distance) and overall quality of life.

Read More

Topics: Heart, stemsaveblog, Heart Failure, clinical trials, Stemcells, Heart Attack, autologousstemcells, Ischemic Cardiomyopathy, heart disease

Mayo Clinic Utilizes Autologous Stem Cells to Treat Heart Failure Patients in First Clinical Study to Target the Regeneration of a Failing Organ

Posted by taylor@stemsave.com on Jun 7, 2013 2:58:53 PM

Researchers at Mayo Clinic have introduced a new therapy using cardiogenically-instructed stem cells that can improve heart health. This is the first clinical study for the targeted regeneration of a failing organ. The Mayo Clinic study represents what we believe to be the gold standard in regenerative treatments – utilizing the patient’s own stem cells for the therapy. As a result of the use of autologous [the patient’s own] stem cells, there were no complications in any of the patients. Every patient in the stem cell treatment group improved. "The benefit to patients who received cardiopoietic stem cell therapy was significant," said Dr. Terzic – the senior author of the study, with improvements in heart pumping function, physical performance (such as walking distance) and overall quality of life.

Read More

Topics: Dr. Terzic, Heart, stemsaveblog, Heart Failure, clinical trials, Stemcells, clinical trial, Heart Attack, Mayo Clinic, autologousstemcells, Ischemic Cardiomyopathy, heart disease

Stem Cells Protect Against Hypoxic-Ischemic Brain Injury

Posted by taylor@stemsave.com on Feb 24, 2013 3:40:00 AM

Hypoxic-Ischemic brain injury can be caused by a number of ailments including cardiac arrest (heart attack), respiratory arrest, incomplete suffocation and more. The incidence in the United States of hypoxic-ischemic brain injuries is 1-8 in every 1000 births. Researchers at Nagoya University have used stem cells from human exfoliated deciduous teeth (SHED) to treat neonatal mice with hypoxic-ischemic brain injuries. They have found that this treatment leads to neurological and pathophysiological recovery of these injuries. These finding indicate that SHED may be utilized in the future for a novel neuroprotective therapy for hypoxic-ischemic brain injuries.

Read More

Topics: deciduous teeth, stemsaveblog, Heart Failure, Stemcells, Heart Attack, autologousstemcells, Ischemic Cardiomyopathy

American Heart Association Reports on Stem Cell Clinical Trials

Posted by pamela@stemsave.com on Dec 18, 2012 12:00:51 AM

 

 

 

 

At this year’s American Heart Association Scientific Sessions, abstracts reporting on clinical trials involving the use of stem cells to treat various types of heart disease, such as Acute Myocardial Infarction and Ischemic Cardiomyopathy, were presented.

Read More

Topics: stemsaveblog, Acute Myocardial Infarction, clinical trials, Stemcells, autologousstemcells, Ischemic Cardiomyopathy

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all